1-2 of 2
Ignacio Gil-Bazo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice

Available to Purchase
Iñaki Eguren-Santamaria, Miguel F. Sanmamed, Sarah B. Goldberg, Harriet M. Kluger, Miguel A. Idoate, Benjamin Y. Lu, Jesús Corral, Kurt A. Schalper, Roy S. Herbst, Ignacio Gil-Bazo
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (16): 4186–4197.
https://doi.org/10.1158/1078-0432.CCR-20-0798
Published: 14 August 2020
View articletitled, PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice
Open the PDF for PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice in another window
Journal Articles

Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance

Free
Mariano Ponz-Sarvisé, Paul A. Nguewa, María J. Pajares, Jackeline Agorreta, María D. Lozano, Miriam Redrado, Ruben Pio, Carmen Behrens, Ignacio I. Wistuba, Carlos E. García-Franco, Jesús García-Foncillas, Luis M. Montuenga, Alfonso Calvo, Ignacio Gil-Bazo
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4155–4166.
https://doi.org/10.1158/1078-0432.CCR-10-3381
Published: 15 June 2011
View articletitled, Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance
Open the PDF for Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance in another window
Includes: Supplementary data